0000000000991270

AUTHOR

Torsten E. Reichert

showing 18 related works from this author

A novel epitope of N-CAM defines precursors of human adherent NK cells

2004

AbstractActivated, adherent natural killer (A-NK) cells represent a distinct subpopulation of interleukin (IL)-2-stimulated NK cells, which are selectively endowed with the increased expression of integrins and ability to adhere to solid surfaces, migrate into, infiltrate, and destroy cancerous tissues. The present study defines the phenotype and functions of precursors of A-NK (pre-A-NK) cells in humans. Peripheral blood pre-A-NK cells, in contrast to the rest of NK cells, express a novel epitope of CD56 neuronal cell adhesion molecule, termed ANK-1, and increased cell-surface levels of integrins. Pre-A-NK cells also express low levels of CD56 and CD161, and some express CD162 receptor, do…

Cytotoxicity ImmunologicIntegrinsLymphoid TissueImmunologyCell CountBiologyCD49bImmunophenotypingEpitopesInterleukin 21NK-92Cell AdhesionHumansImmunology and AllergyCell LineageLectins C-TypeAntigen-presenting cellCells CulturedCell ProliferationMembrane GlycoproteinsLymphokine-activated killer cellStem CellsJanus kinase 3Cell MembraneReceptors IgGAntibodies MonoclonalCell DifferentiationCell BiologyNatural killer T cellCD56 AntigenCell biologyKiller Cells NaturalChemotaxis LeukocyteAntigens SurfaceInterleukin 12Interleukin-2NK Cell Lectin-Like Receptor Subfamily BJournal of Leukocyte Biology
researchProduct

Antigen recognition by T cells: a strong sense of structure

2001

Conformational changeStructural organizationStructural biologyImmunologyT-cell receptorSense (molecular biology)ImmunologyImmunology and AllergyComputational biologyAntigen recognitionBiologyTrends in Immunology
researchProduct

Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma

2003

It is a major challenge to preoperatively identify patients who will profit from surgery of advanced oral cancer. In multimodality therapy, response to neoadjuvant radiation correlates to treatment success. Hence, for preoperative decisions, assessment of treatment response is required. Therefore, we analysed the prognostic significance of glucose metabolism after preoperative radiotherapy. [(18)F]FDG-PET investigations were performed for re-staging 35 patients after neoadjuvant radiotherapy (36Gy) immediately prior to tumor resection. Emission and transmission measurements were obtained and SUV's were calculated for the sites of maximum [(18)F]FDG-uptake. Subpopulations of "low" (SUV4) and…

AdultMaleCancer Researchmedicine.medical_treatmentStandardized uptake valuePremisesFluorodeoxyglucose F18Odds RatiomedicineHumansRadical surgerySurvival rateSurvival analysisNeoadjuvant therapyAgedAged 80 and overAnalysis of Variancebusiness.industryMiddle AgedPrognosisNeoadjuvant TherapySurvival RateRadiation therapyTreatment OutcomeOncologyEpidermoid carcinomaMultivariate AnalysisCarcinoma Squamous CellFemaleMouth NeoplasmsRadiotherapy AdjuvantRadiopharmaceuticalsOral SurgeryNuclear medicinebusinessFollow-Up StudiesTomography Emission-ComputedOral Oncology
researchProduct

Histotomography of the odontoblast processes at the dentine-enamel junction of permanent healthy human teeth in the confocal laser scanning microscope

1998

The translucency of teeth allows the non-destructive subsurface visualisation of their microstructure by confocal laser scanning microscopy (CLSM) at a level of about 150 μm below the surface. The dentine–enamel junction (DEJ) is accessible only directly adjacent to the cervix of the tooth. Therefore teeth have to be sectioned for studying marginal areas of the dental hard tissue. The potential of the technique for (pseudo) three-dimensional visualisation allows the study of an array of individual confocal images, the interpretation of which is similar to that of macroscopic tomographs (CT-scan, MRI). Additionally, the extended focus mode yields the overlay of individual confocal images in …

Materials scienceConfocal laser scanning microscopeEnamel paintConfocalAnatomyHard tissuestomatognathic diseasesDentinal TubuleOdontoblaststomatognathic systemvisual_artConfocal laser scanning microscopyvisual_art.visual_art_mediumGeneral DentistryBiomedical engineeringClinical Oral Investigations
researchProduct

Diagnostik des oralen Plattenepithelkarzinoms und seiner Präkursorläsionen

2007

DermatologyJDDG
researchProduct

The number of intratumoral dendritic cells and ?-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma

2001

BACKGROUND Dendritic cells (DCs) are antigen-presenting cells with a unique ability to cross prime T cells and generate strong antitumor responses. This study evaluates the presence and prognostic significance of DCs as well as functional T cells, which accumulate in the microenvironment in patients with oral squamous cell carcinoma (OSCC). METHODS Immunohistochemistry for S-100 positive or p55 positive DCs and for T-cell receptor (TcR)-associated ζ-chain expression in tumor-infiltrating lymphocytes (TILs) was performed in 132 paraffin embedded specimens from patients with primary OSCC. The median clinical follow-up for the patients was 50 months. The numbers of intratumoral DCs or TILs exp…

Cancer ResearchPathologymedicine.medical_specialtybusiness.industryCancerchemical and pharmacologic phenomenahemic and immune systemsDendritic cellmedicine.diseasemedicine.anatomical_structureOncologyEpidermoid carcinomaAntigenCarcinomamedicineAntigen-presenting cellbusinessLymph nodeSurvival analysisCancer
researchProduct

Defects in the Human Leukocyte Antigen Class I Antigen Processing Machinery in Head and Neck Squamous Cell Carcinoma: Association with Clinical Outco…

2005

AbstractPurpose: Human leukocyte antigen (HLA) class I antigen defects, which are frequently present in head and neck squamous cell carcinoma (HNSCC) cells may provide the tumor with an escape mechanism from immune surveillance. Scanty information is available about mechanisms underlying HLA class I antigen defects in both lesions and cell lines from HNSCC. In this study, we investigate the role of antigen processing machinery (APM) component abnormalities in the generation of deficient HLA class I surface expression of HNSCC cells.Experimental Design: Using immunohistochemistry, Western blot, and RT-PCR analyses we correlated the expression of the IFN-γ inducible proteasome subunits and of…

AdultMaleProteasome Endopeptidase ComplexCancer ResearchPathologymedicine.medical_specialtyBlotting WesternDown-RegulationHuman leukocyte antigenBiologyCell LineInterferon-gammaATP Binding Cassette Transporter Subfamily B Member 3HLA AntigensMultienzyme ComplexesCell Line TumorTumor Cells Culturedotorhinolaryngologic diseasesmedicineCarcinomaHumansATP Binding Cassette Transporter Subfamily B Member 2AgedReverse Transcriptase Polymerase Chain ReactionAntigen processingHistocompatibility Antigens Class ICancerMiddle Agedmedicine.diseaseImmunohistochemistrySurvival AnalysisHead and neck squamous-cell carcinomaGene Expression Regulation NeoplasticCysteine Endopeptidasesstomatognathic diseasesOncologyHead and Neck NeoplasmsCarcinoma Squamous Cellbiology.proteinImmunohistochemistryTAP2ATP-Binding Cassette TransportersFemaleTAP1Clinical Cancer Research
researchProduct

Monoclonal TCR mRNA transcripts are preferentially detected in the TCR variable alpha chain in CD8(+) T-lymphocytes: implications for immunomonitorin…

1999

Clinical trials have started to implement tumor-associated antigens in the form of antigenic peptides in order to augment CD8(+) T-cell responses directed against autologous cancer cells. One of the surrogate markers for successful immunization is the characterization of T-lymphocytes reacting to the immunizing peptide as determined by CDR3-length and DNA-sequence analysis. Most of the recent studies examining ex vivo T-cell responses in patients with cancer have focussed on expression and prevalence of the TCR Beta variable region, predominantly in non-sorted T-cell populations. Here, we show that clonal T-cell receptors (TCRs), as defined by DNA-fragment analysis and DNA-sequencing, appea…

CD4-Positive T-Lymphocytesmedicine.medical_treatmentPopulationUterine Cervical Neoplasmschemical and pharmacologic phenomenaCD8-Positive T-LymphocytesBiologyLymphocytes Tumor-InfiltratingAntigenAntigens NeoplasmNeoplasmsGeneticsmedicineHumansRNA Messengereducationeducation.field_of_studyT-cell receptorCancerhemic and immune systemsGeneral MedicineImmunotherapymedicine.diseaseMolecular biologyClone CellsImmunologyMonoclonalFemaleGenes T-Cell Receptor alphaCD8Alpha chainInternational Journal of Molecular Medicine
researchProduct

Regulation of CD1d expression by murine tumor cells: escape from immunosurveillance or alternate target molecules?

2002

alpha beta+ TCR T cells recognize peptide fragments displayed by MHC-class I or -class II molecules. Recently, additional mechanisms of antigen recognition by T cells have been identified, including CD1-mediated presentation of nonpeptide antigens. Only a limited number of CD1 antigens is retained in the mouse, i.e., the group II CD1 antigens, which are split into CD1D1 and CD1d2. Several T cell subsets have been shown to interact with murine CD1 antigens, including NK cells or "natural T cells" with the invariant V alpha 14 J alpha 281 TCR chain. Even if TAP defects may prevent classical endogenous antigen presentation in tumor cell lines, antigen presentation via CD1 is still functional. …

Cancer ResearchT cellAntigen presentationCD1chemical and pharmacologic phenomenaBiologyNatural killer cellAntigens CD1Immunoenzyme TechniquesInterferon-gammaMiceNK-92Monitoring ImmunologicmedicineCytotoxic T cellAnimalsRNA MessengerAntigen-presenting cellCells CulturedDNA PrimersMice Inbred BALB CReverse Transcriptase Polymerase Chain ReactionAntibodies MonoclonalGranulocyte-Macrophage Colony-Stimulating Factorhemic and immune systemsNeoplasms ExperimentalCytotoxicity Tests ImmunologicFlow CytometryCell biologyGene Expression Regulation NeoplasticKiller Cells NaturalMice Inbred C57BLmedicine.anatomical_structureOncologyCD1DImmunologybiology.proteinCytokinesAntigens CD1dInternational journal of cancer
researchProduct

Diagnosis of oral squamous cell carcinoma and its precursor lesions

2007

Improvement of survival rate and quality of life after treatment of oral squamous cell carcinoma as well as cost reduction requires reliable early diagnosis of the tumor and its precursor lesions. Four different screening methods are primarily employed: toluidine blue staining (visually detected lesions: sensitivity 70-100%, specificity 25-67%), photodynamic diagnosis (sensitivity 94-99%, specificity 60-89%), autofluorescence (no data published so far) and modern oral cytology (sensitivity 80%,specificity 95-100%). Additional analytic procedures such automated image analysis, DNA image cytometry and immunocytochemistry can be used to enhance the low sensitivity of conventional oral cytology…

Pathologymedicine.medical_specialtyBiopsyDermatologyFluorescenceCytologyBiopsyImage Processing Computer-AssistedCarcinomaHumansMedicineTolonium ChlorideSurvival rateDNA Image CytometryNeoplasm StagingMouth neoplasmmedicine.diagnostic_testbusiness.industryMouth MucosaGold standard (test)Prognosismedicine.diseasestomatognathic diseasesAutofluorescenceCarcinoma Squamous CellMouth NeoplasmsbusinessPrecancerous ConditionsJDDG
researchProduct

H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cyto…

2000

H2-M is a major histocompatibility complex (MHC) class II-like molecule that catalyzes peptide binding to MHC class II molecules. Recently, the H2-O heterodimer, encoded by H2-Oa and H2-Ob in the MHC class II region, has been shown to be physically associated with H2-M in B cells and to downregulate H2-M function. Examination of H2-O expression in freshly isolated mouse organs revealed that H2-Oa- and H2-Ob-specific transcripts are present in both lymphoid and nonlymphoid tissues. To evaluate the gene regulation and functional impact of H2-O on antigen presentation, we examined the effects on MHCII, invariant chain (Ii), H2-M, and H2-O gene expression of interleukin (IL)-4, IL-10, and inter…

CD74ImmunologyAntigen presentationchemical and pharmacologic phenomenaMajor histocompatibility complexInterferon-gammaMiceMHC class IGeneticsCIITAAnimalsTissue DistributionRNA MessengerAntigen PresentationHLA-D AntigensMHC class IIbiologyAntigen processingHistocompatibility Antigens Class IINuclear ProteinsMHC restrictionMolecular biologyInterleukin-10Antigens Differentiation B-LymphocyteGene Expression RegulationMice Inbred DBATrans-Activatorsbiology.proteinInterleukin-4PeptidesImmunogenetics
researchProduct

A Double-Blind Randomized Controlled Trial (RCT) of Titanium-13Zirconium versus Titanium Grade IV Small-Diameter Bone Level Implants in Edentulous Ma…

2012

Background: The use of endosseous dental implants has become common practice for the rehabilitation of edentulous patients, and a two-implant overdenture has been recommended as the standard of care. The use of small-diameter implants may extend treatment options and reduce the necessity for bone augmentation. However, the mechanical strength of titanium is limited, so titanium alloys with greater tensile and fatigue strength may be preferable. Purpose: This randomized, controlled, double-blind, multicenter study investigated in a split-mouth model whether small-diameter implants made from Titanium-13Zirconium alloy (TiZr, Roxolid™) perform at least as well as Titanium Grade IV implants. Me…

MaleZIRCONIUM ALLOYSDentistrychemistry.chemical_elementMandiblelaw.inventionDouble-Blind MethodRandomized controlled triallawalloyDental Prosthesis DesignHumansJaw EdentulousMedicinebone level implantBone leveledentulous mandibleORAL-HEALTHAdverse effectGeneral DentistryAgedAged 80 and overTitaniumSUPPORTED OVERDENTURESbusiness.industrySPLIT-MOUTHDental Implantation EndosseousTitanium alloySoft tissueSUCCESSOSSEOINTEGRATED IMPLANTSMiddle Agedddc:617.6Treatment OutcomeDental Prosthesis Designchemistryddc:618.97DENTAL IMPLANTSFemaleImplantZirconiumOral Surgerydouble-blindLocatorbusinessFOLLOW-UPITI IMPLANTSRCTTitaniumClinical implant dentistry and related research
researchProduct

Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude mice

1999

We have previously reported that immune anti-tumor effector cells, both cytotoxic T lymphocytes (CTLs) and IL-2-activated natural killer (A-NK) cells, are effective at eliminating human head-and-neck cancer (HNC) targets in vitro and in vivo in xenograft models. In this study, these 2 types of human effector cell were compared for the ability to prevent the development of lymph node metastases in a metastasis model of human squamous-cell carcinoma of the head and neck (SCCHN) established in nude mice. A tumor cell line, OSC-19, was injected into the floor of the mouth in nude mice, and the tumor grew progressively and metastasized to cervical lymph nodes by day 21. As effector cells, a huma…

Cancer ResearchAdoptive cell transferPathologymedicine.medical_specialtyLymphokine-activated killer cellbusiness.industrymedicine.medical_treatmentImmunotherapymedicine.diseaseNatural killer cellMetastasismedicine.anatomical_structureOncologyCervical lymph nodesmedicineCytotoxic T cellbusinessLymph nodeInternational Journal of Cancer
researchProduct

Das basaloide Plattenepithelkarzinom (BSC) der Mundschleimhaut

1997

The basaloid-squamous carcinoma (BSC) that was first described in 1986 by Wain et al. for the head and neck region is a rare distinct variant of squamous cell carcinoma (SCC). The cardinal histopathologic feature is a biphasic cellular pattern of basaloid and squamous components. BSC has been confused with solid adenoid cystic carcinoma (ACC). Although the number of reported cases is small, BSC appears biologically virulent, with a propensity to aggressive local behavior, early regional and distant metastasis, and subsequent poor survival. We report the clinicopathological characteristics of 4 new cases and compare their immunohistochemical features with those of solid ACC and conventional …

Pathologymedicine.medical_specialtyurogenital systemAdenoid cystic carcinomabusiness.industryvirusesEpithelial carcinomabiochemical phenomena metabolism and nutritionmedicine.diseaseGlandular Patternstomatognathic diseasesOtorhinolaryngologyCarcinomamedicineImmunohistochemistrySurgeryBasal cellOral SurgeryDifferential diagnosisMouth mucosabusinesspsychological phenomena and processesOral and Maxillofacial Surgery
researchProduct

H2-Mβ1 and H2-Mβ2 Heterodimers Equally Promote CLIP Removal in I-Aq Molecules from Autoimmune-prone DBA/1 Mice

2001

Antigen-presenting cells degrade endocytosed antigens, e.g. collagen type II, into peptides that are bound and presented to arthritogenic CD4(+) helper T cells by major histocompatibility complex (MHC) class II molecules. Efficient loading of many MHC class II alleles with peptides requires the assistance of H2-M (HLA-DM in humans), a heterodimeric MHC class II-like molecule that facilitates CLIP removal from MHC class II molecules and aids to shape the peptide repertoire presented by MHC class II to CD4(+) T cells. In contrast to the HLA-DM region in humans, the beta-chain locus is duplicated in mice, with the H2-Mb1 beta-chain distal to H2-Mb2 and the H2-Ma alpha-chain gene. H2-M alleles …

Gene isoformAntigen PresentationMHC class IICD74ArthritisHistocompatibility Antigens Class IICD1AutoimmunityCell BiologyMHC restrictionBiologyMajor histocompatibility complexBiochemistryMolecular biologyCell LineAntigens Differentiation B-LymphocyteMiceAntigenMice Inbred DBAMHC class Ibiology.proteinAnimalsHumansGenetic Predisposition to DiseaseMolecular BiologyJournal of Biological Chemistry
researchProduct

Clonal expansion of melan a-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated pept…

2000

Peptides derived from human tumor antigens have been used in a number of clinical trials to induce specific immune responses against autologous tumors in cancer patients. Although favorable clinical results were observed in single patients, immune responses correlating with tumor regression were either not detected or in case of responses, the T-cell specificity was difficult to demonstrate. In this study, we analyzed antigen-specific T-cell responses induced in the skin and in peripheral blood lymphocytes (PBL) in an HLA-A2-positive melanoma patient. The patient showed major regression of metastatic melanoma under continued immunization with peptides derived from the melanocyte differentia…

Cancer ResearchCellular immunitymedicine.medical_treatmentVitiligochemical and pharmacologic phenomenaMART-1 AntigenMelanocyte differentiationAntigenAntigens NeoplasmmedicineHumansCytotoxic T cellHypersensitivity DelayedMelanomaneoplasmsintegumentary systembusiness.industryMelanomaT-cell receptorImmunotherapyMiddle Agedmedicine.diseaseNeoplasm ProteinsCTL*OncologyImmunologyFemaleImmunizationbusinessMelanoma-Specific AntigensT-Lymphocytes CytotoxicInternational Journal of Cancer
researchProduct

Interleukin-2 and its Receptors in Human Solid Tumours: Immunobiology and Clinical Significance

2006

Human carcinomas were found to express IL-2 R and to produce, but not to secrete, IL-2. Intermediate affinity IL-2Rβγ detected on the surface and in the cytoplasm of carcinoma cells binds exogenous IL-2 at the nanomolar or micromolar concentrations and mediates cell cycle arrest (CCA) possibly through the upregulation of the CDK inhibitor p27kipl expression. In contrast, IL-2Rα is modestly expressed on the cell surface, and it may be involved in the intracrine pathway of delivering endogenous IL-2 to the cell surface. IL-2 is a growth factor for human carcinomas, and as it binds to the high-affinity IL-2R, it promotes cellular proliferation by suppressing expression of p27kipl. It also prot…

Interleukin 2IntracrineCell growthChemistryGrowth factormedicine.medical_treatmentCellCell biologymedicine.anatomical_structureDownregulation and upregulationmedicineReceptorCDK inhibitormedicine.drug
researchProduct

Intravascular ultrasound imaging of arterial wall architecture.

1992

Intravascular ultrasound (IVUS) is a promising new technique for assessing vascular morphology and structure. Controversy exists whether the three-layer appearance of the arterial wall correctly reflects the histologic structures of the intima, media, and adventitia. We performed an experimental study to clarify the three-layer appearance. The vessel wall architecture was analyzed by IVUS on eight different kinds of plastic cylinders, 24 normal blood vessels from pigs, and 59 human arterial segments. A distinct three-layer appearance was observed on all the plastic cylinders when the ultrasound beam was perpendicular to the wall. A three-layer appearance was also seen in the arterial wall, …

SwineAortic DiseasesFemoral arterymedicine.arteryAdventitiaIntravascular ultrasoundmedicineAnimalsHumansRadiology Nuclear Medicine and imagingcardiovascular diseasesAortaUltrasonographyAortic dissectionAortamedicine.diagnostic_testbusiness.industryUltrasoundAnatomyArteriesmedicine.diseasemedicine.anatomical_structurecardiovascular systemUltrasonic sensorCardiology and Cardiovascular MedicinebusinessCalcificationEchocardiography (Mount Kisco, N.Y.)
researchProduct